10-Q Filing

CARDINAL HEALTH INC CIK: 721371 Q1 2020

Filing Information

Form Type	10-Q
Accession Number	`0000721371-19-000127`
Period End Date	20190930
Filing Date	20191107
Fiscal Year	2020
Fiscal Period	Q1
XBRL Instance	a20q110q093019form10-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 42 Cash Flow Statement 56 Stockholders Equity 33 Comprehensive Income 14

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.33B	USD	Point-in-time
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.91B	USD	Point-in-time
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.06B	USD	Point-in-time
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$903.00M	USD	Point-in-time
Preferred Shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred Shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred Shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.21B	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.04B	USD	Point-in-time
Preferred Shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.76B	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.53B	USD	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$8.19B	USD	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$8.45B	USD	Point-in-time
Common Shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Common Shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Common Shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Inventories, net	`InventoryNet`	$12.46B	USD	Point-in-time
Common Shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Inventories, net	`InventoryNet`	$12.82B	USD	Point-in-time
Common Shares in Treasury	`TreasuryStockShares`	34.00M	shares	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$1.85B	USD	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$1.95B	USD	Point-in-time
Common Shares in Treasury	`TreasuryStockShares`	28.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$23.71B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$25.75B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.32B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.36B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$11.81B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$11.66B	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$1.05B	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$1.48B	USD	Point-in-time
Total assets	`Assets`	$39.18B	USD	Point-in-time
Total assets	`Assets`	$40.96B	USD	Point-in-time
Accounts Payable, Current	`AccountsPayableCurrent`	$21.54B	USD	Point-in-time
Accounts Payable, Current	`AccountsPayableCurrent`	$19.72B	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$452.00M	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$631.00M	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$2.19B	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$2.12B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$24.11B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$22.55B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$7.36B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$7.58B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$8.37B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$2.94B	USD	Point-in-time
Authorized500 thousand shares, Issuednone	`PreferredStockValue`	-	USD	Point-in-time
Authorized500 thousand shares, Issuednone	`PreferredStockValue`	-	USD	Point-in-time
Authorized755 million shares, Issued327 million shares at September 30, 2019 and June 30, 2019, respectively	`CommonStockValue`	$2.67B	USD	Point-in-time
Authorized755 million shares, Issued327 million shares at September 30, 2019 and June 30, 2019, respectively	`CommonStockValue`	$2.76B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$5.43B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$371.00M	USD	Point-in-time
Common shares in treasury, at cost: 34 million shares and 28 million shares at September 30, 2019 and June 30, 2019, respectively	`TreasuryStockValue`	$1.79B	USD	Point-in-time
Common shares in treasury, at cost: 34 million shares and 28 million shares at September 30, 2019 and June 30, 2019, respectively	`TreasuryStockValue`	$2.04B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-101.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-79.00M	USD	Point-in-time
Total Cardinal Health, Inc. shareholders' equity	`StockholdersEquity`	$6.33B	USD	Point-in-time
Total Cardinal Health, Inc. shareholders' equity	`StockholdersEquity`	$900.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$2.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$3.00M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.33B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.91B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.06B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$903.00M	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$40.96B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$39.18B	USD	Point-in-time

Income Statement 42 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$35.21B	USD	1 Quarter
Revenue	`Revenues`	$37.34B	USD	1 Quarter
Cost of Goods and Services Sold	`CostOfGoodsAndServicesSold`	$35.66B	USD	1 Quarter
Cost of Goods and Services Sold	`CostOfGoodsAndServicesSold`	$33.55B	USD	1 Quarter
Gross margin	`GrossProfit`	$1.67B	USD	1 Quarter
Gross margin	`GrossProfit`	$1.68B	USD	1 Quarter
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.11B	USD	1 Quarter
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.16B	USD	1 Quarter
Restructuring and employee severance	`RestructuringCharges`	$32.00M	USD	1 Quarter
Restructuring and employee severance	`RestructuringCharges`	$30.00M	USD	1 Quarter
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$156.00M	USD	1 Quarter
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$132.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$511.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-1.00M	USD	1 Quarter
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-19.00M	USD	1 Quarter
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-5.67B	USD	1 Quarter
Operating earnings/(loss)	`OperatingIncomeLoss`	$-5.26B	USD	1 Quarter
Operating earnings/(loss)	`OperatingIncomeLoss`	$816.00M	USD	1 Quarter
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$-3.00M	USD	1 Quarter
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$-14.00M	USD	1 Quarter
Interest expense, net	`InterestExpense`	$77.00M	USD	1 Quarter
Interest expense, net	`InterestExpense`	$66.00M	USD	1 Quarter
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-5.34B	USD	1 Quarter
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$736.00M	USD	1 Quarter
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-423.00M	USD	1 Quarter
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$142.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$594.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$-4.92B	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Net earnings/(loss) attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$593.00M	USD	1 Quarter
Net earnings/(loss) attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$-4.92B	USD	1 Quarter
Basic (in shares)	`EarningsPerShareBasic`	$1.95	USD	1 Quarter
Basic (in shares)	`EarningsPerShareBasic`	$-16.65	USD	1 Quarter
Diluted (in shares)	`EarningsPerShareDiluted`	$1.94	USD	1 Quarter
Diluted (in shares)	`EarningsPerShareDiluted`	$-16.65	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	305.00M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	296.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	306.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	296.00M	shares	1 Quarter
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.48	USD	1 Quarter
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.48	USD	1 Quarter

Cash Flow Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net earnings/(loss)	`ProfitLoss`	$594.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$-4.92B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$245.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$234.00M	USD	1 Quarter
Impairments and (gain)/loss on sale of investments	`LossOnSaleOfInvestments`	$2.00M	USD	1 Quarter
Impairments and (gain)/loss on sale of investments	`LossOnSaleOfInvestments`	-	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$511.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-1.00M	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$20.00M	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$19.00M	USD	1 Quarter
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$29.00M	USD	1 Quarter
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$21.00M	USD	1 Quarter
(Increase)/decrease in trade receivables	`IncreaseDecreaseInReceivables`	$302.00M	USD	1 Quarter
(Increase)/decrease in trade receivables	`IncreaseDecreaseInReceivables`	$-229.00M	USD	1 Quarter
(Increase)/decrease in inventories	`IncreaseDecreaseInInventories`	$178.00M	USD	1 Quarter
(Increase)/decrease in inventories	`IncreaseDecreaseInInventories`	$-356.00M	USD	1 Quarter
Increase/(decrease) in accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.81B	USD	1 Quarter
Increase/(decrease) in accounts payable	`IncreaseDecreaseInAccountsPayable`	$559.00M	USD	1 Quarter
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$84.00M	USD	1 Quarter
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-5.21B	USD	1 Quarter
Net cash provided by/(used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-653.00M	USD	1 Quarter
Net cash provided by/(used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$365.00M	USD	1 Quarter
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$72.00M	USD	1 Quarter
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$58.00M	USD	1 Quarter
Purchase of available-for-sale securities and other investments	`Purchaseofavailableforsalesecuritiesandotherinvestments`	$4.00M	USD	1 Quarter
Purchase of available-for-sale securities and other investments	`Purchaseofavailableforsalesecuritiesandotherinvestments`	$3.00M	USD	1 Quarter
Proceeds from sale of available-for-sale securities and other investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$2.00M	USD	1 Quarter
Proceeds from sale of available-for-sale securities and other investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$1.00M	USD	1 Quarter
Proceeds from Sale of Property, Plant, and Equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	1 Quarter
Proceeds from Sale of Property, Plant, and Equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$740.00M	USD	1 Quarter
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-73.00M	USD	1 Quarter
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$679.00M	USD	1 Quarter
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	-	USD	1 Quarter
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	$-2.00M	USD	1 Quarter
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$1.00M	USD	1 Quarter
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$74.00M	USD	1 Quarter
Net tax proceeds/(withholdings) from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$-13.00M	USD	1 Quarter
Net tax proceeds/(withholdings) from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$-13.00M	USD	1 Quarter
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$146.00M	USD	1 Quarter
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$150.00M	USD	1 Quarter
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$600.00M	USD	1 Quarter
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$350.00M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-585.00M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-764.00M	USD	1 Quarter
Effect of exchange rate changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$2.00M	USD	1 Quarter
Effect of exchange rate changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-8.00M	USD	1 Quarter
Net increase/(decrease) in cash and equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.32B	USD	1 Quarter
Net increase/(decrease) in cash and equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$282.00M	USD	1 Quarter
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.21B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.04B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.76B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.53B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.21B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.04B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.76B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.53B	USD	Point-in-time

Stockholders Equity 33 line items

Line Item	Tag	Value	Unit	Period
Balance at beginning of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at beginning of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.33B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.91B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.06B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$903.00M	USD	Point-in-time
Treasury, balance at beginning of period (in shares)	`TreasuryStockShares`	34.00M	shares	Point-in-time
Treasury, balance at beginning of period (in shares)	`TreasuryStockShares`	28.00M	shares	Point-in-time
Treasury, balance at beginning of period	`TreasuryStockValue`	$1.79B	USD	Point-in-time
Treasury, balance at beginning of period	`TreasuryStockValue`	$2.04B	USD	Point-in-time
Net Earnings/(Loss)	`NetIncomeLoss`	$593.00M	USD	1 Quarter
Net Earnings/(Loss)	`NetIncomeLoss`	$-4.92B	USD	1 Quarter
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$594.00M	USD	1 Quarter
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$-4.92B	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-22.00M	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-4.00M	USD	1 Quarter
Employee stock plans activity, net of shares withheld for employee taxes	`StockIssuedDuringPeriodValueShareBasedCompensation`	$7.00M	USD	1 Quarter
Employee stock plans activity, net of shares withheld for employee taxes	`StockIssuedDuringPeriodValueShareBasedCompensation`	$6.00M	USD	1 Quarter
Payments for Repurchase of Common Stock	`PaymentsForRepurchaseOfCommonStock`	$600.00M	USD	1 Quarter
Payments for Repurchase of Common Stock	`PaymentsForRepurchaseOfCommonStock`	$350.00M	USD	1 Quarter
Dividends	`Dividends`	$143.00M	USD	1 Quarter
Dividends	`Dividends`	$141.00M	USD	1 Quarter
Stockholders' Equity, Other	`StockholdersEquityOther`	$2.00M	USD	1 Quarter
Balance at end of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at end of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.33B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.91B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.06B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$903.00M	USD	Point-in-time
Treasury, balance at end of period (in shares)	`TreasuryStockShares`	34.00M	shares	Point-in-time
Treasury, balance at end of period (in shares)	`TreasuryStockShares`	28.00M	shares	Point-in-time
Treasury, balance at end of period	`TreasuryStockValue`	$1.79B	USD	Point-in-time
Treasury, balance at end of period	`TreasuryStockValue`	$2.04B	USD	Point-in-time

Comprehensive Income 14 line items

Line Item	Tag	Value	Unit	Period
Net earnings/(loss)	`ProfitLoss`	$594.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$-4.92B	USD	1 Quarter
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-17.00M	USD	1 Quarter
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-3.00M	USD	1 Quarter
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-1.00M	USD	1 Quarter
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-5.00M	USD	1 Quarter
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-22.00M	USD	1 Quarter
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-4.00M	USD	1 Quarter
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-4.94B	USD	1 Quarter
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$590.00M	USD	1 Quarter
Less: comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Less: comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$-4.94B	USD	1 Quarter
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$589.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.